III/ril/sic efficacies FG 7142 Ident ifying both the env ironmental and biological variables that promote and maintain high alcohol-seeking or alcohol self-administration behavior is key to unders tanding the disorder of alcohol abuse and alcoholism (Li et al. 1991). Selective breed ing methodology has demonstrated convincingly thai there is genetic int1u-ence on alcohol-seeking beh.wior ( Li et aL 1991). Currently there are four pairs (high and low) of rat lines that differ in alcohol preference (Ericksson and Rusi 1981; Mardones and Segozia-Riq uelene 1983; Li ct a l.
Ident ifying both the env ironmental and biological variables that promote and maintain high alcohol-seeking or alcohol self-administration behavior is key to unders tanding the disorder of alcohol abuse and alcoholism (Li et al. 1991) . Selective breed ing methodology has demonstrated convincingly thai there is genetic int1u-ence on alcohol-seeking beh.wior ( Li et aL 1991) . Currently there are four pairs (high and low) of rat lines that differ in alcohol preference (Ericksson and Rusi 1981; Mardones and Segozia-Riq uelene 1983 ; Li ct a l. 1991). These pharmacogene tica lty different animallincs provide useful tools for investigat ing alcohol's neuroche mical and neurophMmacological efrects (McBride ct 011. 1992). The alcohol-preferring (P) and -nonpreferring (NP) rats are one pair of rats that h;;we been devetopt..--d through selective breeding fro m a Wistar stock for their divergent preference for EtOH (Lumeng et a l. 1977; Li et a t. 1987) . With food a nd water ad libitum, P ra ts voluntarily consume at least 5 g l kg body weightl day of an unflavored EtOll solution (10% v I v) , whereas N P ra ts consis te ntly cons ume less than 1 g / kg body weight I day. ResponSt.'"-Contingent EtOH intake without the use of sweetene rs has a lso been demonstrated in P rats with concentra tio ns as hig h as.3{)o/" (v / v) (Penn et a1. 1978;  Wa ller e t a l. 1984; Murphy e t a1. 1989); howevcr, N P rals rt'Spond very little for alcohol concentrations exct.'t.>d ing 5% (v I v) (Murphy e t a1. 1989), unll.'SS EtOH initiation procedures are employed (Samson ct a l. 1989a ). Thus, rats of the P line may be used as a model for studying environmental variables that mediate alcohol cons umptio n.
Some informa tio n is available on the environmenta l variables that CM initiate EtOH self-administration in the N P rat. Silmson and his colleagues (1989b) , as well as others (Ras!'mick et al. 1993) , have successfully employed the sucrose-fading technique to initiate EtOH drinking to phannacologically releva nt levels in N P ra ts. Blood alcohol concentratio ns (SACs) have been reported in the range o f 30 to 110 mg / dl fo llowing a 30-minu te operant session (5.. ,mson e t a l. 1989b; also SLoe Rassnick e t nl. 1993). Prev ious l"CSCarch from o ur laboratory has emploYI.-d it modifica tion of the palatability-induced polydipsia method (Kulkosky 1978) to initiate 24-hou r continuous EtOH consum ption in r ra ts (Caito e t a l. 1990). This procedure consists of presenting a nima ls a two-bottle choice of \\fa ter and a "cockta il " comprised o f 3% (w I v) polyc05e, 0.5% (w I v) NaC!, a nd 0.125% (w / v) s.,ccharin, w ith EtOH added in 2% increments every third day until a concentratio n of lO' Yo (v / v) is obtained. Although the amount of the cocktail consumed declines .1S EtOH concentratio n increases, EtO,., intake levels s tabilize and remain mensurable. 61\Cs were approxima tely 31 and 61 mg 'Yo at 30 and 60 minutes, respectively, into the dark cycle (see Methods), ind icating that pharmacologically relevant EtOH levels were obtained . Gatto and cOl1eagues (1990) further indica too that this modified pa latability-induced polydipsia method was ca pable of mainta ining hig h EtOH drinking in NP rats fo r several mo nths.
EtOH self-admi nistratio n in roden ts can be a lten:. >d by a varie ty of neuro pharmacologica l agents that affect different neurotransmitter systems (Weiss and Koob 1991 ; McBride e t al . 1992) , suggesting tha t several neurotransmitte r systems may interact to mediate EtOH reinforcement. Considerable n...osearch implica tes the CA BAA-BDZ rt.'Ceptor complex as one neu rorecepto r tha t plays a n important role in the reinforcing actions of EtOH (fo r N CUROI'SYCHOI'11AItMACOUJCY 19'J6-VOl. 1-1, NO. I review, sec June e t a l. 1994a). Prev io us research w ith P and N P rats has s hown that ROI5-4513, a partial BDZ inverse agonist, selectively atten uates EtOH intake with· ou t affecting water cons umptio n during limited fluid ava ilabi lity (McBride et al. 1988) . Recently, we Qune l'I al. 1995; a lso sec June et a l. 1993) compa red the abili ty of several BDZ inverse agonists IROI 5-350S (s.1rmazcnil), Fe 7142, ROI9-4603, DMC MI w ith a bro.,d spectrum of intrinsic e fficacil.'S (1·laefely 1990; Richards e t OI l. 1991) w ith tha t o f ROI5-4513 in modifyi ng the reinforcing properties of EtO H in the P rat. Besides exerting prolonged supprt.'Ssion of EtOH intake, R019-4603 was a~ proximately 10 to 20 times more pote nt tha n ROl5-4S13 in attenua ting EtO H intake. The results with DMCM, a full negative a llosteric mod ula to r of CI\ BAergic activity (Richards e t a l. 199 1), showed tha t, a ltho ug h it was ca· pablc of decreasing EtOH intake, the reduction appeared to be part of a general overa ll dciicit on moti· vated behaviors, insofa r as reductions were also observed in the control fluid and food intake. 5,;1fmazc-nil did not a lter EtOH intake, and FC 7142 de mon· stra ted selective a ntagonis m only at modera te to high doses (16 a nd 32 mg/ kg), presumably reflecting the lower affi nity of these compounds at the UDZ receptor (Sieghart e t a l. 1987; Lister and N ull 1988) .
The objective of the pn.'SCllt study was to determine the gencraliz.'lbility of o ur previous findings with P rats by showing tha t inverse agonists w ith different intrinsicef· ficacies effectively a ntago nize p.1 Iatability-induced EtOH intake of N P rats. Specifica lly, the BDZ inverse agonists FG 71 42, ROI9-4603, a nd DMCM were eva luated for their ability to selectively suppress EtOH intake, following initiation us ing a palatabili ty-induced polydipsia method (Kulkosky 1978; Gatto c t a l. 1990 ). In addition, to exa mine the abi lity of a BDZ receptor ligand w ith vcry weak intrinsic efficacy (Haciely 1984) , but a t the agonist end of the continuum, ROI 6-6028 (bretazenil), a UOZ partial agonist, was a lso investigilted. Bretazenil, like many congeners of flumazenil (e.g., sarmilzcnil) , exerts hig h uffini ty for 8DZ receptors (Richards e t a1. '1991) and is currently under cli nica l investigation as a pharmacotherilpcutic agent for the trea tment of a nxie ty disorders in humans (Moreau et al. 1991) . H~nce, information o n the ability of this drug to modify the reinforcing properties of EtOH wou ld be of clinica l interest.
METHODS

Subjects
Experimenta lly naive adu lt male rOll .. (II = 7) of the selectively bred N P li ne (5-37 gene ra tion) were individua lly hOUSl.>d in wire-mesh stainless steel cages in a telllperatufe-Controlled (21"<:) room o n a 12:12 reversed light:da rk cycle (lig hts off a l 0900 ho urs). Rats were pre-\WIIOI'SYOIQI'HARMACOlOGY 19'J6.-VOL. 14, NO. 1 \iously tested for free.<hoice drinking of unflavored l~(v / v) EtCH (Lumeng et al. 1977) , a nd EtCH intake a\wagcd 0.63 = 0.20 g / kg/ day. Approxima te ly 1 month ('lapsed before the anima ls received any further exposure to EtO H . Body weights a t the beginning of the study ranged from 370 to 400 g. P.J.lJlability-l nduced Ethan ol Intake by NP Rats
The rats were acclimah...oci over 2 weeks to 22-hour fluid deprivation schedule, while a ll fluid access was restricted to the dark phase of the cycle between 1000 and 1200 hours. Food (Te klad Diet #700 1, Harlan Industries, Indianapolis, IN) was available ad libitum . Animals remained on this schedule throughout the remainder of the experi me nt. This experimental appTTh'lch was used because of the reported short half-life (Mandema et a l. 1992) and short duration of action (d' Argy et al. 1987 ) of some of the BDZ ligands and the ability to measure drug actions on both the cocktail and water intake when food was available ad libitum . The position of the bottles was a lterna ted dai ly to avoid the development of any position preferenct. >s.
During the initial de pri va tion phase, a nimals were provided water in two 100-011 grad ua lt:.' d Richter bOllk'S for 2 ho urs daily. After 2 wl.'t!ks of acclimation to the Auid-deprivation schedule, a modification of the procedures of Ku lkosky (1978) was implemented to initiate EiOH intake (see Caito ct al. 1990 , for comple te details of the procedure). Briefly, before EtOH was added, the "cocktail " consis ted of 3% (w I v) polycose, 0.5' >' 0 (w I v) NaCl, and 0.125' >' 0 s.,ccharin (w I v). EtO H was added to the cockta il in 2% (v I v) increments evcry third day until a 10% (v / v) EtOH concentration was a ttained. Once the drinking patterns of both the EtO H cocktail and water had stabilized, Tw(..oen-SO veh icle injections wcre administered prior to the drinking sessions to acclimate the anima ls to the injection procedure. Intakes were measured at 15-, 30-, 60-, and 120-m inute intervals durIng the 2-hou r period o f fluid availabi lity. Subjects were weighed twice per week to monitor body weight gain. Animals were given daily access to the two Auids for I month prior to the experimenta l dmg treatments.
Drugs
Drugs were prepared as no e muls ion by powde r agita- Benzodiazepines Alter Ethanol Intake 57 (brctazenil; tetracycl ic imidazo I I.5-a ) pyrrolo-(2,l c )1 , 4-benzodia .. ..epi ne) from Hoffmann-La Roche (Nut ley, NJ) was tcsted at 8, 16, and 32 mg/ kg. The full BOZ inverse agonist, DMCM (methyl 6,7-d imethoxy-r-ethylBet:l-cllrboline-3-carboxyla te), from Sigma Chem icill Co. (St. Louis, MO) WilS tested at 1, 4, and 8 mg / kg. All drug solutions were prcpan..>d imml>clia tely prior to injections and ad ministcn.."CI intrapcritonea l1y (lr) in a volume of I ml / kg body weight. l\vccn-SO vehicle was adminis tered as the control injection for all drug conditions. Drug treatments were administert"CI in a random order. To control for any residual dmg carryover effects, pretrea tments with Tween-SO vehicle were ad miniSlcn."CI every 3 to 4 days, after baseline d rinking patterns were rt.."t.'Stablished. At the conclus io n of the study, the EtOH was removed from the cocktail and a nima ls were provided access to the polycosc solution and wa ter 2 hours daily for an addi tio nal 2 weeks. Drug treatments that showed selectivity in attenuating EtOH intake were evaluated for their ability selectively to alter the 3,. .. polycosc solution in the absence of EtOH a nd water.
Me thod of Analysis
Two analyses were conducted o n the data; the fi rst for EtOH, a nd the second for water intake. The analysis consisted of a 16 X 4 repeated-measures analys is of variance (ANOVA). The first facto r represented treatment condition (Tween-SO vehicle; 0.02, 0.04, 0.08, and 0.1 5 mg / kg ROI9-4603; 1, 4, 8, and 16 mg/ kg FG 7 142; 8, 16, a nd 32 mg/ kg ROI6-6028; I, 4 and 8 mg / kg DMCM; and a combination condition comprising 16 mg/ kg FC 7142 + 0.08 mg/ kg ROI9-46(3). The second factor represented cons umption interva l (15, 30, 60, and 120 minutes). The combination condition was administered to evaluate w hethe r a n inverse agonist with 11 [3-c.uboline s tructure would N.'Semble the imidazobenzodiazcpine ROI5-451 3 Qune et al. 1993) in its ability to attenuate R019-4603's s uppressant effects on EtOH self-administration. The Newman-Kellis a posterio ri test was conducted on painvise compa risons of group means.
Previous ly, we (June et a l. 1994b) demonstrated that in P rats mai ntained o n 24-hour free-c.hoice access to 100/ .. (v I v) unflavored EtO H and wilter, ROI9-4603 selectively su ppressed EtOH intake up to 32 hours postdrug administration. ik.ocause of R019-4603's potentiill the ra peutic usefulness in the development of less toxic agents in reducing ilbnorma l alcohol-seeking behavior, our p revious work w ith P rats was replica ted in the NP line. He nce, to exam ine the time course of R019-4603, separate two-way ANOVAs (d rug condition x time) were cond ucted on the EtO H and water data 24 hours postdrug ad minis tratio n for the four R019-4603 dose conditions (0.02, 0.04, 0.08, a nd 0.15 mg/ kg) compa red w ith the vehicle control.
RESULTS
Consumplion of the polycose solution dL'Cr£aS(.od from approximately SIlO :t 1.3 ml during days 1-3 (no EtOH) 10 approximately 23.8 ::: 2.8 ml when the EtOH concentration (v / v) WilS 2% (days 4-6). It then decreaS(.'(i further to 14.3 ::: 0.64 mJ, when EtOH was 4% (days 7-9); only additional sma ll decreilses of intake occurred when the EtCH concentration was 6% or highcr. When the s0-lution contained 100/0 EtCH, intakes were 11.2 ::: 1.1 ml (2.1 ::: 0.20 g / kg/2 hours) prior to beginning vehicle and drug injections. Figure 3B shows tha t at the IS-minute inte rval, the 16-mg/ kg dose s ignificantly reduced wa ter consumption (" < .05), whereas the 1-, 4-, and 8--mg/kg doses did not al te r wa ter intake (p > .05). During the 30-, 60-, and 12O-mi nute intervals, no significa nt diffe renn.'S were observed. Figure 4A shows cons umption o f the EtOH solution for vehicle injections com pared w ith the full ~-ca rbo l ine inverse agonis t, DMCM. Sign ificant suppression of EtOH intake was a pparent at the 6O-minute interval with the 8-mg/ kg dose of DMCM (p < .05). In contrast, ma rked eleva tions in intake were observed a t the 120-m inute interva l fo llow ing the 4~ and B-mg/kg d ose conditions (ROI 6-6028). A different profile of effects cmerg<..od for brctazcnil relati ve to the other lesK-d inverse agollislS (above) \Vh"'n compared with the control cond ition. Specifically, the lower dose (8 mg/ kg) did not alter drinking of the EtOH solution at the initial IS-minute cons umption interva l (p > .05), but the two higher doses (16 a nd 32 mg/ kg) ma rkedly elevated EtOH intake (p < with the O.08-mg/ kg dose of R019-4603. EtOH intake for the animals unde r the combina tion cond ition was nearly identica l to that of animals given 0.08 mg/ kg ROI9-4603 a lone across each consumption interval (p > .05). Compared wi th the R01 9-4603 condition, the combination condition was without effect on water intake at the 15-, 30-, a nd 6O-minule interva ls. However, wa ter intake was s ubstil nlially s uppressed a t the 120-mi nutc interval oom pan:. xl with the ROI 9-4603 condition (p < .01). .u,ro was the most potent agent tha t blocked EIOH inlake. To furt her e levate the degree to which RQ 19-4603 alters ingesti ve beha viors. the e ffects o f RQ1 9-4603 (0.08 and 0.1 5 mg / kg) we re studied in rats provided 2 ho u rs daily acct'SS to the cockta il solutio n witho ut EtOH for 2 weeks. A s ingle-facto r ANOVA fo r drug conditio n (vehicle, 0.08, a nd 0. 15 ROI 9-4603 mg/ kg) w as conducted on the EtOH and w ater data sepa ra te ly. As seen in Figure 7A , RO I9-4603 a t the 0.08-a nd O. l 5-mg / kg doses significa ntly reduced consumptio n of the polycosc solution at the 120-m inute in terval compa red with the vehicle control (1' < .05), n:.'s ulting in a s ig ni ficant trea tme nt '" 4.09, p < .0041. A s ignificant red uction in wate r cons umptio n occurred o nly fo r the O. l S-mg / kg dose condition at the IS-mi n ute interva l (p < .05) (sec Fig ure 7U ), resulting in a Sig nifi cant treatme nt cond itio n-by-cons umptio n inte rval inte ractio n (F(6,JO) = 4.63", < .00 11.
DISCUSS ION
The present s tudy investigated the abi lity of various BDZ recepto r ligands with different intrinsic effi cacies to modify pala tability-induced EtCH cons ump tion in L P rats. N P rats we re used as a model to study effects on environmentally innuenc~od EtOH drinking. Because NP rats do not readily consume EtOllto pharmacologically relevant levels, the palatability-induced polydipsia method (Kulkosky 1978; Callo el al. 1990 ) and nuid deprivation were used 10 initiate EtOll intake. Simi l.u to previous studies (s..,mson el al. 1989b; Gallo el al. 1990 ; Rassnick e t al. 1993), the dala reported here cle;uly show that environmental processes can be manipulated to enhance EtOH intake in rats that normally avoid subs l .. ntial EtOH consumption. Average EtOH intake was 1.95 and 2.1 :::!;. 0.2 g/kg/2 hr during the 60 and 120 minute intervals, respectively. Blood alcohol concentrations (BACs) were nol determined in the present study, howe\'er, Ga tto et al. (1990) showed that NP rats attained BACs of approximately 60 mg% 1 hour into the dark cycle when given unlimited access to the Polycose/EtOH cocktail and water. Th~ findings indicate that Ihe initiation procroure of the current s tudy was s uccessful in inducing Ihe NP r<ll to self-adminis ter pharmacologically relevant concentrations of EtOH . In agn..>ement with a previous report (s..,mson et al . 1989b ), the current s tudy demonstrated thai, unlike P (Murphy el al. 1986) and nonl'oCit.octLxI s tock rats (s..,mson 1986), NP rats distributed thei r EtOH drinking in sma ller bouts over the length of the session. Specifically, animals maintained a moderate level of intake over 60 minules, with negligible intake occurring during the 120-minute inte rval (sec Figure IA) . Gatto et al. (1990) suggested that NP rats I\.--duce their drinking of the 3% Polycose + EtOH solution when 8ACs reach a point where the aversive effects of the EtOH begin to counter the highly palatable sweet taste of the polycosc solution. This hypothesis is consistent with previous research indicating that, in contrast to P rals, the postingestional pharmacological properlies of EtOH al compa rati vely moderate BACs arc aversive the NP rat (Waller et al. 1984; Froehlich e t al . 1988; Uice and Kiefer 1990) .
The primary purpose of the prt..'SCnt s tud y, however, was to exa mine the ability of BDZ rc-ceptor ligands with different intrinsic efficacies selectively to alter palatability-induced EtOH intake. The major findings of the s tudy are that some compounds acting via the GABA-BDZ rc-ceptor complex can modify drinking patterns in the NP rat line.
Consistent w ith our previous work in P rats under limited Oune et al. 1993 ) and continuous 24-hour access Oune et al . 1994b ), the present s hldy demonstrates thai a single injection of the pole nt BDZ inverse agonist, R019-4603 (0.04 and 0.15 mg/ kg) given acutely, markLodly suppressed EtOH intake during the initial 15 minutes of the 2-hour consumption period in NP rail.. In addition, the highest dose continued to suppress intake al the 3O-minu te interval. Water intake showed no differences from veh icle control intakes or showed increases across two of the consumption intervals (e.g., 30 and 120 minutes), although the highest dose (0.15 mg/ N(UROf'SVCI!Of'IIAIU.-I"COLOCY 1~\lOL 14, Mol. kg) nonscl.xtively reduced intake of both nuids at I IS-minute interval. MOI\.'Over, when rats were given choice between water and the polycose solution, wi out EtOJ-I. only the O.t5-mg/ kg dose supprcssc..>d wa intake during the IS-minule interval (see Figure 7A -B~ Given the reported consistency of EtOH drinking' NP rats (Mc Bride et al. 1988; s', mson et al. I 989b) un limited access protocols in the absence of dnlg Ire me nts, one possible interpretation of the results served in the current study during the 30-to 120-minu posld rug administr,ltion time inten'als may be that i creases in EtOH or water drinking renect elevations d to pharmacologically induced effects on Auid inta during the 1S-minute interva l (Weiss and Koob 1991 However, because the pretre<llment times with the BD ligands were all s imilar, and none of the agents w~ given after the initial hour of nuid intake, the dcgl\.'C which eleva ted EtOH or water intake during the JO.. to 12().minute consumption inten'als represent compcns.ttory increases Cannot be dete rmined .
The l"CSults of the pre.ent study further confirm Ou et al. 1993) thai a single injection of R019-4603 OIl tht 0.15-and O.OS-mg/ kg dose levels arc capable of exerting prolonged attenuation of EtOH intake; at. 24-hour postdrug administration, the O.1S-mg/ kg dose of ROI9-4603 s ignificantly reduced EtOH intake during the 15-minu te inlerval, and the O.08-mg/kg dose completely supprt.>SSed intake at the 6O-minute interval ( Figure 2A~ Water consumption was s ignific .. ntly decreased at thr IS-minute inten'al 24 hours after the 0.04-and O.08-mg/ kg dose of ROI9-4603, but it was increased at the 30-minute inten'al for the 0.02-mg / kg dose, and at the I~ minute interval for the 0.02-, 0.04-, and O.tS-mg/ kg dOSL"S ( Figure 2B ). Recently, we demonstrated thai when r rats were provided 24-hour continuous access to unnavored EtOH a nd WOller in their home cage, EtOH intake during the 8 hours afler R019-4603 (0.075-0.]) mg/ kg) was substantially reduced; however, during thr 9-to 24-hour interval, EtOH intake did not differ from control values. At the 24-to 32-hour post-ROI 9-460J ad· ministration, s ignificant s uppression was again SCttI with the higher R019-4603 dose (0.30 mg/kg). Water drinking in that s tudy was not altered or s howro increases a t the 8-, 24-and 32-hour consumption intervals. The differential eff.xts obsen'ed with ROI9-4603 24 houTS after admin istration bctwL'e1l animals under continuous acct$S in the previous study and limited access drinking in the present study may be relaled to thr pattern of EtOH drinking under the two tyPt.'s of schedules on the one hand, and the manner in which EtOu intake is measured on the other (for review s..."C Murphy etal.1986;a lso Junectal. I99-1b).
Unlike the profile of effects seen with ROI9-4603, the f3.-<:arboline partial inverse agonist, FC7142, did not reduce EtOH intake at any of the doses testL"Ci at the IS. minute and JO-minute interval s, although reductions were noted fo r the l-mg/ kg dose at the 6O-m inute internl (see Figure 3A ). These findings with FG7142 could beattributed to the drug's low affinity for BDZ receptor IBracstrup et al. 1983) . A previous study (Lister 1987) found that FC7142 is approximately 7 to 13 timt'S less potent Ihan ROI5-451 3 in blocking the EtOH-induced depressant action (2 g/kg) on exploration. However, rerent work (June et al. submitted) in our laboratory has shown that a 16-and 32-mg/ kg dose of FG7142 effecti\·clyantagonized EtOH intake in P rats. The findings of the present s tudy also contrast with previolls work by Samson et al. (1989a) in outbred rats, who found that FG7142 (3-10 mg/ kg) dosc-dcpendently antagonized EtCH-reinforced lever-pl\.'SS responding. The discrepant findings among these studies may be attributed to St'\'cral methodological differences. One of the most s..1-lient differences is the maintenance of the NP rats in the present study on the polycose + EtOH regimen while the animals in our previous work (June et 011. 1995) , and the study by 5.:1mson et al. (1989) were maintained on unflavored EtOH. Samson ct al. (1989a) have demonstrated that EtOH-reinforced responding is considerably more sensitive to the attenuating effects of BDZ in\·c!"SC agonists (ROI5-4513 and r-c n-l2) than to sucrosereinforced I"\.>sponding. Thus, because of the purported low affinity of FG 7142 (or the BDZ rL-'Ceptor, along w ith the simultancous usc o( the polycose polydipsia method and a fluid-deprivation schedule, it is possible that higher doses of FG 71-12 may have attenuated EtOH intOlke.
Results with the full p-carboline inverse agonist D~1CM showed that, with the exception of the lowcst dose (I mg / kg), there was a generalized behavioral sup· pl'l.'SSclnt effect on fluid int.lke and level of activity. Moreover, with the highest dose, 500k of the animals exhibited seizure activity evidenced by myoclonic jerking of the head and forelimbs. These effects persisted for approximately S minutes. This generalized behavior .. l ~upprcssant effect in NP rats CM possibly be altribuh: . . >d toa greater n.>duction in GABAergic transmission caused by the full inverse agonist.
The UDZ partial agonist, bretazenil (RO I 6-6(28), did not alter EtOH intake with the lowest dose (8 mg / kg); however, the higher doses (16 and 32 mg/ kg) substantiallyelevated EtCH intake during the initial IS-minute consumption period. A significan t reduction in waler intake occurn:.od at the IS-minute interval for the 8-mg / kg dose, and an increase occu rred at the 120-minute inlerval for the 32-mg / kg dose (see Figures SA and B) .
These findings contrast with the recent work by Rassnick and her colleagues (1993) who showed that chlordiazepoxide (2.5-10 mg/ kg) did not alter EtOH-or waterfl'in(orced responding in NP r.lts, although nonsignificant increases were observ(od for the 2.5-and 5-mg / kg doses in P rats. Others (Beaman et al. 1984) , using a Iwobottle choice tcst between a sweetened EtOH solution Bcnzodiazepincs Alter Ethanol lnt.lke 63 and water in stock rats, found that chlordiazepoxide (3-12 mg/ kg) generally incrcaSL"'<i total fluid intake, but it did not alter the rats' propensity to self-admi nister EtOH. 5.1mson and Grant (1985) , using a concu rrent scht.odule proa.>dure, demonstrated thot chlordiazepoxide generally reduced EtOH-reinforCf.od n. >spondi ng and intake. Despite the consistent decreoscs o f EtOH-reinforced I"\. >sponding and intilke, no overa ll statis tically significant compensatory increase in the alternative fluid (e.g., sucrose, water) was observed for either of tiu. 'Se measures.
Several reports have suggt'Sh_ '<i that BOZ agonists (Cooper and Francis 1982; Cooper 1983) and partial agonists (Moreau ct al. 1991) are capable of increasing in-};t'Stive behaviors. Bretazc.nil has opproximotely a 10-fold higher affini ty for the I3DZ T(.'Ccptur than diazepam, and it produces anticonnict effccts at much lower dQS('S and over a wider dose range (Richards et al. 1991) . The potent dipsogenic effects of bretilzenil on EtCH drinking at IS minutes and water drinking at 120 minutes with the high dose (32 mg/ kg) (sec Figures SA and 13 ) may be related to its ability to exert relatively high BDZ receptor occupancy. Hence, the increase in EtOH intake in the current study may simply be an indirect con~ quence o( bretazenil generally enhancing ingestive be--haviors. An alternative interpretation of the findings with bretazeniJ on EtOH intake is that brelazenil acts as an anxiolytic in NP rats by blocking some of the aversive properties associated with EtCH consumption, thel"\.>by enhancing the reinforcing effects of EtOH (Rassnick et al. 1993) . As mentioned, the aversive properties of EtOl1 may be related to its postingestional effects in the NP rat (Bice and Kiefer 1990; W.lller et al . ]984). NP rats are reported to have a lower threshold for the aversive effccts of EtOH in conditioned taste aversion studit..>s (Froc.hlich et oJ. 1988) .
Un like our previous findings with ROI5-4513 Qune et al . 1993) , FG 7142 (16 mg/ kg) did not alter the actions of R019-l603 on EtOH intake (sec Figures 6A and B) .
These findings and its wcak potency in blocking the reinforcing actions of EtOH further confinn the weak affinily of FG 7142 ot BDZ receptors compared with ROI5-4SI3. FG 71 42 also doc'S not antagonize the intoxicating action of EtCH (Suzdak e t al. 1986; Lister and Durcan 1989) . A related hypothesis regarding the weak potency of FG 7142 to ontagonize EtOH's octions pertains to Ihe completc failure of FG 7142 to bind at diazepam-insensitive (01) s itcs in the cerebellum (Tu rncr cl al. 1991) . Although the significance of 01 sites are not well understood, Turner and his colleogucs (1991; also Olsen and Tobin 1990) Sllggt'Stl'<i that the selective/ unique efficacy of compounds in blocking EtOH's action may be related to their efficacy at different receptor subtypes (Olsen and Tobin 1990) . Unlike j3-carboline negative allosteric modulators (e.g., FG 7142, ~CCE, ~CCM), imidazobenzodiazepines show high affinity binding at diazcpamsensitive (OS) and 01 sites (Turner e t al. 1991; . At 0 1 s ites R01 9-4603 binds at K, -2.6 nM and at K, -0.2 nM at OS sites . ROI5--451 3 binds with the same affinity (Kd -4.5 nM) to both OS and 01 sites (Turne r ct al. 1991) . O thers have also confirmed the ROI5--4513 DI/DS potcncy ratio of about I. Simila rl y, the partial agonis t bretazcni l binds at 01 s ites with a compa ra ble affinity (K, ~ 10 nM), but c1assicill BOZ agonists s uch as diilzepam and midazolam posst--'SS an ICso > 10,000 nM (Wong and Skol nick 1992). These findings s uggest the possibility that the pharmacophore for annelated 1, 4-diazepines that possess high afftnity to 0 1 BDZ receptors is fundamentally different at the OS BDZ n..>ccptors (Wong and Skoln ick 1992) . The identification of high-affinit y ligands at 01 BOZ receptors may assist in elucidating the pharmacological importance of these sites in the behav iora l actions of EtOH.
Although food intake was not detennilU . . '!1 in the present study, with the exception of bretazenil at the highest doses (16 and 32 mg/ kg) and a t the 8-mg/ kg DMCM dose condition, nonc of the drug treat mcnts have been obscrv(.od to exert any significant alteration on food intakc in f"->ely feeding P rats provided 4-hour limit(.>d access to lO'Yo EtOH and S<1ccharin solutions (June et al. 1993) . It is also worth noting that lxxiy weights for the animals in the present study were consistent w ith weight ga in profiles for male NP rats in previous studies, s uggesting that the caloric balance was maintaim . . od throughout the experiment . In su mmary, the present findings confirm that environmental processes can be manipulated to initiate EtOH intake in rats of the P line (Samson et al. 1989b; Galto et al. 1990 ). The results also confirmed (June et al. 1993 (June et al. , 1994b ) that doses of ROI9-4603 (0.08 and 0.15 mg/ kg), may be capable of reducing EtOH intake 24 hours after administration, allhough some effects on WOller drinking may also occur. Moreover, compared with the othe r anxiogcnic ligands (e.g., Fe 71 42, DMCM) ROI9-4603 was the most potent agent to block EtOH intake. However, it should be noh . .
'CI that a scledivc s uppression of EtOH intake with all ROI9-4603 dOSl.'S was not obscrv(.od in the present study with NP rats, as havc been observed during ad libitum drinking situations with Prats Oune et OIl. 1993 OIl. , 1994b . The anxiolytic agent brctazenil ( 16 and 32 mg / kg) markedly increased EtQI-1 consumption during the initial 15 minutes compan..od with control levels, although the increased consumption may result from a general dipsogcnic effect on fluids. Although caution should be used in extrapolating the findings of the current study to human situations, there is a s uggestion that moderate to high doses of bretazenil may potentiate EtOH intake via an indirect interaction on ingestive behaviors . . It is important to note that the animals in the present study were 22-hour NCUROl"SYCHOI'IlARMACOLOGY 1996-VOl.... 14, NO.1 fluid deprived and initia ted EtOH intakc in the horr.r cage. 11ll1s, the rt'Sults of the present s tudy may nOi gencra li:;o..e to s ubjects in ad libitum drinking and EtOHreinforced responding sihlations. Given the preS(' 11t findings with N P ra ts, and our previous work with ROlS-451 3 (McBride et al. 1988; June et al. 1994a~ ROI9-4603 Qune et al. 1993 , 1994b , and the p-carbolinr inverse agonists FG 7142 and DMCM Qune et al. 1995) in P rats, it appears that the property of the ligand (ligand s tnacture, e.g., a nnelated 1, 4-diazepine) may bt important in modifying EtOH intake . . Similarly, bretazt'-nil, at the agonist end of the BOZ con tinuum, also binds to 01 sites and increases EtOH intake to a greater degree than classical agonists (e.g., chlordiazepoxide, diazepam) that do not confer DI (5.1mson and Grant 1985; Rassnick et al . 1993) . Thus, the data of the present study with both anxiogenic ligands and the anxiolytic bretazenil, along with previous resea rch from our laboratory Ouncet al. 1993, J994b, submitted) and others (Samson and Grant 1985; Rassnick et al. 1993 ) appear consistent with a qualitative (i.e., imidazobenzodiazcpinc-sch::ctive) as well as a quantitative (relative receptor affini ty) difference in thc interaction of these ligands (affinity for 01 s ites). Together, the present findings support existing evidence in P and oulbred ra ts (for review, Sl.."'C June e t 31. 1994a, 1994b) suggesting that BOZ receptor ligands may modify neuronill processes that mediate some reinforcing and /or aversive properties of alcohol. They further s uggest a potcntial importance of the GABA,,-BOZ receptor complex in mediating palatability· (environmentally) induced EtOH drinking even in rats seiL>ctivcly bred for low alcohol preference.
